William J. Lowery
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
William J. Lowery has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Angeles Alvarez Secord
Duke Cancer Institute 5 Durham, NC
1 shared publication - Beverly G. Reed
Peak Fertility, Plano, Texas
1 shared publication Chad A. Hamilton
Gynecologic Oncology Service, Department of OB/GYN, Walter Reed National Military Medical Center, Bethesda, MD, United States; Department of Defense Gynecologic Cancer Center of Excellence, Women's Health Integrated Research Center at Inova Health System, Annandale, VA, United States
1 shared publication- Charles A. Leath
University of Alabama Birmingham, Birmingham, AL, USA
1 shared publication Chunqiao Tian
Precision Therapeutics Inc., Pittsburgh, PA, United States
1 shared publication- Emily Meichun Ko
Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA
1 shared publication
Latest Publications
- 1 February 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 136 (2) , 328-335
Survival advantage of marriage in uterine cancer patients contrasts poor outcome for widows: A Surveillance, Epidemiology and End Results study
- 1 February 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 136 (2) , 328-335
Survival advantage of marriage in uterine cancer patients contrasts poor outcome for widows: A Surveillance, Epidemiology and End Results study
- 1 November 2012
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 67 (11) , 702-703
Surgical Staging for Endometrial Cancer in the Elderly—Is There a Role for Lymphadenectomy?
Most gynecologic oncologists believe that use of lymphadenectomy (LND) after hysterectomy in women with advanced-stage endometrial cancer improves the 5-year disease-specific survival (DSS). At present, the role of postsurgical LND in the management of women with early-stage endometrial cancer is controversial. The 5-year survival among patients with early-stage disease is high (>98%). With the higher risk for morbidity with LND, many oncologists find it difficult to justify lymph node dissection in such low-risk patients. It is generally accepted that some patients with preoperative grade 1 disease will be upgraded to grades 2 and 3 at the final pathologic evaluation. This retrospective study compared the effect of the inclusion or omission of systematic LND on DSS at 5 years for early- or advanced-stage endometrial cancer in a population of women 80 years or older. Data on women who underwent primary hysterectomy for nonserous, non–clear cell endometrial carcinoma from 1988 to 2006 were obtained from the Surveillance, Epidemiology, and End Results (SEER) program. Patients were stratified by age (≤70, 70-79, and ≥80 years). Disease-specific survival at 5 years was compared in the LND and no LND cohorts using the Kaplan-Meier method with the log-rank test. The cancers were stratified by postoperative International Federation of Gynecology and Obstetrics grade as follows: well-differentiated (grade 1; 33.8%, n = 2303), moderately differentiated (grade 2; 38.5%, n = 2621), and poorly differentiated or undifferentiated (grade 3; 27.6%, n = 1881). Disease-specific survival in a simulated population of women with preoperative grade 1 disease was calculated using a weighted average survival accounting for those upgraded to grades 2 and 3 on the final pathology report. The study population was composed of 6805 women with endometrial cancer 80 years or older. No difference was found in DSS at 5 years between the LND and no-LND groups for grades 1 and 2: DSS rates with and without LND were 93.4% and 94.5%, respectively, for grade 1 (P = 0.36), and 84.4% and 85% for grade 2 (P = 0.97). In contrast, there was significant improvement in DSS at 5 years for women with grade 3 (65.9% with LND and 60.9% without LND; P = 0.002). In the cohort of subjects older than 80 years with preoperative grade 1 disease, the 5-year DSS rates were 91% in the LND group and 92% in the no-LND group. These findings indicate that systematic LND in women older than 80 years is associated with improved DSS for high-grade endometrial cancer but does not improve DSS for low-grade disease.
- 1 November 2012
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 67 (11) , 702-703
Surgical Staging for Endometrial Cancer in the Elderly—Is There a Role for Lymphadenectomy?
Most gynecologic oncologists believe that use of lymphadenectomy (LND) after hysterectomy in women with advanced-stage endometrial cancer improves the 5-year disease-specific survival (DSS). At present, the role of postsurgical LND in the management of women with early-stage endometrial cancer is controversial. The 5-year survival among patients with early-stage disease is high (>98%). With the higher risk for morbidity with LND, many oncologists find it difficult to justify lymph node dissection in such low-risk patients. It is generally accepted that some patients with preoperative grade 1 disease will be upgraded to grades 2 and 3 at the final pathologic evaluation. This retrospective study compared the effect of the inclusion or omission of systematic LND on DSS at 5 years for early- or advanced-stage endometrial cancer in a population of women 80 years or older. Data on women who underwent primary hysterectomy for nonserous, non–clear cell endometrial carcinoma from 1988 to 2006 were obtained from the Surveillance, Epidemiology, and End Results (SEER) program. Patients were stratified by age (≤70, 70-79, and ≥80 years). Disease-specific survival at 5 years was compared in the LND and no LND cohorts using the Kaplan-Meier method with the log-rank test. The cancers were stratified by postoperative International Federation of Gynecology and Obstetrics grade as follows: well-differentiated (grade 1; 33.8%, n = 2303), moderately differentiated (grade 2; 38.5%, n = 2621), and poorly differentiated or undifferentiated (grade 3; 27.6%, n = 1881). Disease-specific survival in a simulated population of women with preoperative grade 1 disease was calculated using a weighted average survival accounting for those upgraded to grades 2 and 3 on the final pathology report. The study population was composed of 6805 women with endometrial cancer 80 years or older. No difference was found in DSS at 5 years between the LND and no-LND groups for grades 1 and 2: DSS rates with and without LND were 93.4% and 94.5%, respectively, for grade 1 (P = 0.36), and 84.4% and 85% for grade 2 (P = 0.97). In contrast, there was significant improvement in DSS at 5 years for women with grade 3 (65.9% with LND and 60.9% without LND; P = 0.002). In the cohort of subjects older than 80 years with preoperative grade 1 disease, the 5-year DSS rates were 91% in the LND group and 92% in the no-LND group. These findings indicate that systematic LND in women older than 80 years is associated with improved DSS for high-grade endometrial cancer but does not improve DSS for low-grade disease.
- Open Access
- 1 June 2011
- Published by Elsevier in Gynecologic Oncology
- Vol. 121 (3) , 643
Erratum to “Hospice enrollment for terminally ill patients with gynecologic malignancies: Impact on outcomes and interventions” [Gynecol. Oncol. 118 (2010) 274–277]
- 1 June 2011
- Published by Elsevier in Gynecologic Oncology
- Vol. 121 (3) , 643
Open AccessErratum to “Hospice enrollment for terminally ill patients with gynecologic malignancies: Impact on outcomes and interventions” [Gynecol. Oncol. 118 (2010) 274–277]